Japan has a long food culture of lactic acid bacteria — fermented milk drinks, pickles, miso — and Japanese supplement makers work with both live bacteria and heat-treated cells. Brands abroad ask for “Japanese lactic acid bacteria” because of that reputation.
The single most important fact for this ingredient is that research results belong to a strain, not to a species or to “lactic acid bacteria” in general. A brand that designs around that fact makes a product it can defend. This guide explains why, and what to decide before a Japan-made product.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a lactic acid bacteria product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
Why the strain matters
Two strains of the same kind of bacteria can give different results in trials, so evidence for one strain cannot be borrowed for another.
A strain is identified by its genus, species and a strain designation — for example Bifidobacterium animalis subsp. lactis followed by a code. A 2014 meta-analysis in The American Journal of Clinical Nutrition shows why the code matters.
| Study | What was pooled | Reported result |
|---|---|---|
| Systematic review and meta-analysis, The American Journal of Clinical Nutrition 2014 | 14 randomised controlled trials, 1,182 adults with functional constipation | Overall, probiotics shortened gut transit time and increased weekly bowel movements; the effect was significant for B. lactis but not for Lactobacillus casei Shirota. The authors urged caution because of high heterogeneity and risk of bias |
The study population had a digestive condition. That is a fact about the research, and it is a reason not to transfer the result into claims for a product sold to healthy people.
For your product:
- Buy a named strain with its own studies, not a generic species.
- Cite only studies on that strain, at a comparable daily amount.
- Keep the strain identity on your specification, so your regulator and your customers can trace it.
Checked against the published abstract on 25 September 2026.
Live bacteria or heat-treated cells
Live bacteria (“probiotics”) and heat-treated cells (“postbiotics”) are different ingredients with different definitions, specifications and shelf-life questions.
| Live bacteria (probiotics) | Heat-treated cells (postbiotics) | |
|---|---|---|
| Definition | ”Live microorganisms that, when administered in adequate amounts, confer a health benefit on the host” (ISAPP consensus, 2014) | “A preparation of inanimate microorganisms and/or their components that confers a health benefit on the host” (ISAPP consensus, 2021) |
| Specification | Live cell count, usually as colony-forming units at the end of shelf life | Cell count or amount of cells, not viability |
| Formulation | Sensitive to heat, moisture and oxygen; packaging and storage matter | More stable; easier in tablets, drinks and confectionery |
| Evidence | Belongs to the live strain tested | Belongs to the heat-treated preparation tested — not automatically to the same strain alive |
Heat-treated lactic acid bacteria are well established in Japanese foods, and they suit dosage forms where live bacteria would not survive processing.
💬 Unsure whether live or heat-treated suits your market and format? We compare the options against your concept. Tell us your market.
What Japanese products say
In Japan, lactic acid bacteria and bifidobacteria appear in Foods with Function Claims notified for functions such as helping to maintain a good intestinal environment and supporting regular bowel habits.
The notified wording describes functions of a healthy digestive system, each supported by evidence for the specific strain in that product. Outside Japan the rules differ widely. In the European Union, for example, many national authorities have treated the word “probiotic” itself as a health claim that needs authorisation. Confirm your market’s position on the word before you design the pack.
Wording that stays on safe ground
Describe the strain and what it was studied for; never attach a disease to the product.
| Safer wording | Wording to avoid |
|---|---|
| ”Contains B. lactis [strain code], studied for bowel regularity” | Names of digestive diseases, or “treats” anything |
| ”Billions of live cells at the end of shelf life”, with the actual figure | Cell counts at manufacture only |
| ”Heat-treated lactic acid bacteria” | Calling heat-treated cells “live” |
How lactic acid bacteria are formulated
Live bacteria favour capsules and dry powders with moisture-proof packaging; heat-treated cells fit almost any form.
- Strain and supplier. Choose a strain with its own published studies, and ask the supplier for the strain identity and its specification.
- Amount per serving. For live bacteria, specify the count guaranteed at the end of shelf life, not only at manufacture.
- Dosage form and packaging. Hard capsules, powder sticks and tablets are common. Blister packs or aluminium pouches protect live bacteria from moisture.
- Companion ingredients. Dietary fibres and oligosaccharides are common partners. Each needs its own check against Japanese food law and your market’s rules.
- Storage and shipping. Agree the storage conditions the shelf-life claim depends on, and how the product will travel.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Lactic acid bacteria used in foods are common in Japan. The risk usually sits in companion botanicals in “gut” or “detox” formulas, some of which Japan treats as medicines. See the Japan-made supplement OEM page, and our GABA guide for a second example of reading limited evidence honestly.
Before you ask for a quotation
A factory can quote accurately once the strain, the count, the form and the packaging are fixed.
- Strain identity, live or heat-treated
- Amount per serving at the end of shelf life
- Dosage form and packaging
- Companion ingredients and their amounts
- Storage and shipping conditions
- Countries you will sell in, and first order and annual volume
💬 Ready to design a Japan-made lactic acid bacteria product? Send us the concept — strain, amount, form and the countries you will sell in.
Frequently asked questions
1. Why does the strain matter so much?
Because results differ between strains. A 2014 meta-analysis found a significant effect on bowel movement frequency for B. lactis but not for L. casei Shirota. Evidence for one strain cannot be used for another.
2. What is the difference between probiotics and postbiotics?
Probiotics are live microorganisms that confer a health benefit in adequate amounts. Postbiotics are preparations of inanimate microorganisms or their components that confer a health benefit. Both definitions come from ISAPP consensus statements.
3. How should the cell count be stated?
For live bacteria, state the count guaranteed at the end of shelf life. A count at manufacture alone overstates what the customer receives.
4. Are heat-treated lactic acid bacteria common in Japan?
Yes. They are well established in Japanese foods and fit tablets, drinks and confectionery where live bacteria would not survive processing.
5. Can I use the word “probiotic” on my pack?
It depends on your market. Many EU national authorities have treated the word itself as a health claim needing authorisation. Check your market’s rules first.
Sources: “The effect of probiotics on functional constipation in adults: a systematic review and meta-analysis of randomized controlled trials”, The American Journal of Clinical Nutrition 2014; ISAPP consensus statement on the scope and appropriate use of the term probiotic, Nature Reviews Gastroenterology & Hepatology 2014; ISAPP consensus statement on the definition and scope of postbiotics, Nature Reviews Gastroenterology & Hepatology 2021; Consumer Affairs Agency notifications for Foods with Function Claims. Checked on 25 September 2026.